SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-06-010624
Filing Date
2006-03-20
Accepted
2006-03-17 17:37:24
Documents
4
Period of Report
2006-01-31

Document Format Files

Seq Description Document Type Size
1 v038095.htm 10-Q/A 1363678
2 v038095_ex31-1.htm EX-31.1 22391
3 v038095_ex31-2.htm EX-31.2 21947
4 v038095_ex32.htm EX-32 7243
  Complete submission text file 0001144204-06-010624.txt   1416706
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-25169 | Film No.: 06697015
SIC: 2834 Pharmaceutical Preparations